The molecular mechanisms underlying the effects of niclosamide in malignancies are divers and related to its interference with crucial cancer pathways such as PI3K/Akt, Wnt/beta-catenin, Jak/STAT, and NF-κB signaling, which have been identified as potential targets in different cancers [101]. The gene discussed is AKT1; the disease is cancer.